Vaccine Update Press Briefing

The video discusses the European Medicines Agency's stance on the AZED vaccine, emphasizing its benefits in preventing COVID-19 despite concerns about side effects. It highlights ongoing investigations into venous thromboembolic events (VTE) and reassures that no increased risk has been found. The importance of vaccination in saving lives is stressed, with a call to action for public participation.

What is the stance of the European Medicines Agency regarding the AZED vaccine?

• It is not effective against COVID-19.

• It should be discontinued.

• Its benefits outweigh the risks.

• It causes significant side effects.

What are the ongoing investigations focusing on regarding the AZED vaccine?

• Its effectiveness against new variants.

• Its link to venous thromboembolic events.

• Its storage requirements.

• Its cost-effectiveness.

What does current evidence suggest about the risk of VTE with the AZED vaccine?

• There is a high risk.

• There is no increased risk.

• The risk is unknown.

• The risk is increasing.

According to Professor Ramsey, what is crucial for the effectiveness of vaccines?

• Public debates on their safety.

• Approval by multiple regulators.

• Timely administration to people.

• Proper storage in fridges.

What is the public's reaction to the vaccination campaign as observed by the speaker?

• Indifference towards getting vaccinated.

• Fear of potential side effects.

• Enthusiasm to receive the vaccine.

• Confusion about vaccine availability.